BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 7669663)

  • 21. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF.
    Antinori A; Ammassari A; De Luca A; Cingolani A; Murri R; Scoppettuolo G; Fortini M; Tartaglione T; Larocca LM; Zannoni G; Cattani P; Grillo R; Roselli R; Iacoangeli M; Scerrati M; Ortona L
    Neurology; 1997 Mar; 48(3):687-94. PubMed ID: 9065549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4-Positive T-Cell Primary Central Nervous System Lymphoma in an HIV Positive Patient.
    Nael A; Walavalkar V; Wu W; Nael K; Kim R; Rezk S; Zhao X
    Am J Clin Pathol; 2016 Feb; 145(2):258-65. PubMed ID: 27124906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of lymphotropic herpesvirus DNA by polymerase chain reaction in cerebrospinal fluid of AIDS patients with neurological disease.
    Broccolo F; Iuliano R; Careddu AM; Trovato R; Lico S; Blanc PL; Mazzotta F; Ceccherini-Nelli L
    Acta Virol; 2000; 44(3):137-43. PubMed ID: 11155355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus in acquired immune deficiency syndrome (AIDS) and non-AIDS primary central nervous system lymphoma.
    DeAngelis LM; Wong E; Rosenblum M; Furneaux H
    Cancer; 1992 Sep; 70(6):1607-11. PubMed ID: 1325277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.
    Nguyen-Them L; Costopoulos M; Tanguy ML; Houillier C; Choquet S; Benanni H; Elias-Shamieh R; Armand M; Faivre G; Glaisner S; Malak S; Vargaftig J; Hoang-Xuan K; Ahle G; Touitou V; Cassoux N; Davi F; Merle-Béral H; Le Garff-Tavernier M; Soussain C;
    Eur J Cancer; 2016 Jul; 61():69-76. PubMed ID: 27156226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).
    Sasayama T; Nakamizo S; Nishihara M; Kawamura A; Tanaka H; Mizukawa K; Miyake S; Taniguchi M; Hosoda K; Kohmura E
    Neuro Oncol; 2012 Mar; 14(3):368-80. PubMed ID: 22156547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr viral load as a marker of lymphoma in AIDS patients.
    Fan H; Kim SC; Chima CO; Israel BF; Lawless KM; Eagan PA; Elmore S; Moore DT; Schichman SA; Swinnen LJ; Gulley ML
    J Med Virol; 2005 Jan; 75(1):59-69. PubMed ID: 15543571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma.
    Song Y; Zhang W; Zhang L; Wu W; Zhang Y; Han X; Yang C; Zhang L; Zhou D
    Sci Rep; 2016 Dec; 6():38671. PubMed ID: 27924864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients.
    Cinque P; Vago L; Dahl H; Brytting M; Terreni MR; Fornara C; Racca S; Castagna A; Monforte AD; Wahren B; Lazzarin A; Linde A
    AIDS; 1996 Aug; 10(9):951-8. PubMed ID: 8853727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-barr virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus infection and central nervous system disorders.
    Portolani M; Cermelli C; Meacci M; Pietrosemoli P; Sabbatini AM; Cerri MC; Guaraldi G; De Rienzo B
    New Microbiol; 1999 Oct; 22(4):369-74. PubMed ID: 10555209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive predictive value of Epstein-Barr virus DNA detection in HIV-related primary central nervous system lymphoma.
    Cinque P; Cingolani A; Bossolasco S; Antinori A
    Clin Infect Dis; 2004 Nov; 39(9):1396-7; author reply 1397-8. PubMed ID: 15494920
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system.
    Weinberg A; Li S; Palmer M; Tyler KL
    Ann Neurol; 2002 Nov; 52(5):543-8. PubMed ID: 12402250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement by the polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosis and AIDS-related non-Hodgkin's lymphomas.
    Laroche C; Drouet EB; Brousset P; Pain C; Boibieux A; Biron F; Icart J; Denoyel GA; Niveleau A
    J Med Virol; 1995 May; 46(1):66-74. PubMed ID: 7623009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients.
    Correa RM; Fellner MD; Durand K; Redini L; Alonio V; Yampolsky C; Colobraro A; Sevlever G; Teyssié A; Benetucci J; Picconi MA
    J Med Virol; 2007 Apr; 79(4):401-7. PubMed ID: 17311329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus and AIDS-related primary central nervous system lymphoma. Viral detection by immunohistochemistry, RNA in situ hybridization, and polymerase chain reaction.
    Guterman KS; Hair LS; Morgello S
    Clin Neuropathol; 1996; 15(2):79-86. PubMed ID: 8925601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma.
    Whitcup SM; Stark-Vancs V; Wittes RE; Solomon D; Podgor MJ; Nussenblatt RB; Chan CC
    Arch Ophthalmol; 1997 Sep; 115(9):1157-60. PubMed ID: 9298057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain.
    Bossolasco S; Nilsson A; de Milito A; Lazzarin A; Linde A; Cinque P; Chiodi F
    AIDS; 2001 Jun; 15(9):1109-13. PubMed ID: 11416712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.
    Gandhi MK; Hoang T; Law SC; Brosda S; O'Rourke K; Tobin JWD; Vari F; Murigneux V; Fink L; Gunawardana J; Gould C; Oey H; Bednarska K; Delecluse S; Trappe RU; Merida de Long L; Sabdia MB; Bhagat G; Hapgood G; Blyth E; Clancy L; Wight J; Hawkes E; Rimsza LM; Maguire A; Bojarczuk K; Chapuy B; Keane C
    Blood; 2021 Mar; 137(11):1468-1477. PubMed ID: 33202420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
    Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
    Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.
    Li J; Tang X; Luo X; Liu L; Li D; Yang L
    Ann Hematol; 2023 Aug; 102(8):2153-2163. PubMed ID: 37289220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.